Atropos Health
Founded Year
2019Stage
Series B | AliveTotal Raised
$50.33MValuation
$0000Last Raised
$33M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+90 points in the past 30 days
About Atropos Health
Atropos Health specializes in transforming healthcare data into actionable evidence for the healthcare and life sciences sectors. The company offers solutions that support clinical decisions, optimize health systems, and accelerate clinical research by leveraging a vast network of patient records and analytics tools. Atropos Health primarily serves the healthcare industry, including health systems and life science companies, by providing insights for formulary design, quality improvement programs, and clinical trial emulations. It was founded in 2019 and is based in New York, New York.
Loading...
Atropos Health's Product Videos
_thumbnail.png?w=3840)
_thumbnail.png?w=3840)
ESPs containing Atropos Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
Atropos Health named as Challenger among 15 other companies, including IQVIA, Tempus, and Datavant.
Atropos Health's Products & Differentiators
ChatRWD™ (Chat Real World Data)
ChatRWD is a generative AI tool that delivers clinical answers more accurately than LLMs such as ChatGPT and Google Gemini. It leverages real-world data from the Atropos Evidence™ Network, which contains over 300 million anonymized patient records. The impact of ChatRWD extends beyond its technical capabilities; it represents a shift in how healthcare data is accessed and utilized. Built on Atropos Health technology, GENEVA OS™, ChatRWD is the first application to incorporate chat-to-database functionality, allowing users to generate high-quality evidence rapidly without compromising data security. GENEVA OS operates locally at the customer’s site, ensuring no patient-level clinical or claims data is exposed to LLMs.
Loading...
Research containing Atropos Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Atropos Health in 7 CB Insights research briefs, most recently on May 16, 2025.
May 16, 2025 report
Book of Scouting Reports: 2025’s AI 100
Apr 24, 2025 report
AI 100: The most promising artificial intelligence startups of 2025
Aug 21, 2024
The clinical trials tech market map
Jan 11, 2024
The generative AI in healthcare market map
Expert Collections containing Atropos Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Atropos Health is included in 5 Expert Collections, including Digital Health.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
AI 100 (All Winners 2018-2025)
200 items
Digital Health 50
50 items
Artificial Intelligence
10,049 items
AI 100 (2025)
100 items
Atropos Health Patents
Atropos Health has filed 62 patents.
The 3 most popular patent topics include:
- medical equipment
- surgical procedures and techniques
- digestive system surgery
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/27/2021 | 3/25/2025 | Abdomen, Medical equipment, Surgical removal procedures, Digestive system surgery, Surgical procedures and techniques | Grant |
Application Date | 7/27/2021 |
|---|---|
Grant Date | 3/25/2025 |
Title | |
Related Topics | Abdomen, Medical equipment, Surgical removal procedures, Digestive system surgery, Surgical procedures and techniques |
Status | Grant |
Latest Atropos Health News
Jul 2, 2025
The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity. Photo: Martin Barraud/Getty Images European private equity firm Nordic Capital has acquired a majority stake in data analytics company Arcadia through a newly announced strategic partnership. Boston-based Arcadia is a healthcare data platform that supplies providers with tools for network administration, managing payments, improving processes regarding visit access and referrals, and overseeing preauthorization. Nordic Capital, which is headquartered in Stockholm, Sweden, says that under its umbrella, Arcadia will be able to accelerate its expansion. The deal is anticipated to close in the latter half of 2025. The acquisition marks an exit for previous investor Peloton Equity, whose predecessor firm Ferrer Freeman acquired Arcadia Solutions in 2012. "Nordic Capital’s investment is a powerful endorsement of the strength of Arcadia’s platform and confidence in our ability to deliver value by improving outcomes and reducing costs," Michael Meucci, Arcadia’s president and CEO, said in a statement. "This milestone marks a new phase of growth for Arcadia, grounded in the same mission, but with even stronger backing to scale smarter, invest faster, and accelerate innovation to meet the growing demand for data-driven intelligence in healthcare." THE LARGER TREND Last month, Arcadia acquired Sage Technologies , which develops implementation tools and managed services for accountable care organizations (ACOs). Last year, California-based real-world data platform Atropos Health announced that Arcadia joined its health portfolio , giving Arcadia's provider customers and life sciences users access to Atropos' offerings. Atropos offers AI tools, evidence generation, analytics augmentation and data evaluation to help physicians access real-world evidence to guide clinical decisions and research. In 2023, GuideHealth , an AI-enabled value-based care provider for health systems, announced it acquired Arcadia's value-based care services division and managed services organization. GuideHealth also signed an agreement with Arcadia to utilize its data analytics platform to power the acquired offerings, which will work with its predictive and generative AI.
Atropos Health Frequently Asked Questions (FAQ)
When was Atropos Health founded?
Atropos Health was founded in 2019.
Where is Atropos Health's headquarters?
Atropos Health's headquarters is located at 169 Madison Avenue, New York.
What is Atropos Health's latest funding round?
Atropos Health's latest funding round is Series B.
How much did Atropos Health raise?
Atropos Health raised a total of $50.33M.
Who are the investors of Atropos Health?
Investors of Atropos Health include Breyer Capital, Emerson Collective, Presidio Ventures, McKesson Ventures, Cencora Ventures and 10 more.
Who are Atropos Health's competitors?
Competitors of Atropos Health include Aetion and 8 more.
What products does Atropos Health offer?
Atropos Health's products include ChatRWD™ (Chat Real World Data).
Who are Atropos Health's customers?
Customers of Atropos Health include Stanford Medical Center, https://www.mayoclinic.org/ , Everycure and TD2.
Loading...
Compare Atropos Health to Competitors
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
Datavant operates as a health data platform company that focuses on health data security, accessibility, and usability. The company provides a platform and network that allow for data exchange and interoperability within the healthcare ecosystem, allowing organizations to connect and use real-world data. Datavant serves health plans, healthcare providers, life sciences, government, non-profits, and data analytics sectors. It was founded in 2017 and is based in Phoenix, Arizona.
Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.
3Aware specializes in software surveillance for the medical device industry, focusing on post-market life cycle management. The company offers a platform that integrates access, analysis, and alerts for medical device post-market surveillance, utilizing patient health data and AI. The platform links individual patients to their longitudinal experience with specific medical devices and facilitates the mining, analysis and surveillance of both structured and unstructured EHR content. 3Aware primarily serves medical device manufacturers, providing solutions to post-market clinical follow-up and surveillance. 3Aware was formerly known as Post Markets Insights. It was founded in 2022 and is based in Indianapolis, Indiana.
Promptly Health offers real-world evidence solutions within the healthcare sector. The company provides services that include generating knowledge from clinical, socio-economic, and claims data, as well as collecting longitudinal patient-reported data and digital biomarkers. Promptly Health serves life sciences, healthcare providers, and healthcare payers. It was founded in 2017 and is based in Porto, Portugal.
Dandelion operates as a product development platform for clinical AI in the healthcare data sector. The company provides access to longitudinal health records, enabling healthcare innovators to train, validate, and commercialize their algorithms. It primarily serves AI developers, medical device manufacturers, and life sciences sectors. It was founded in 2020 and is based in Syosset, New York.
Loading...